Insider · CIK 0002027010

James Andrea S.

Reports to the SEC for 1 company · NASHVILLE, TN

sec.gov

Transactions

Companies

Filings

CIK

0002027010

Forms 4 and 5

Insider transactions

17 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-03-26	IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+28.3K sh	—	—	217,358
2026-03-26	IMDXInsight Molecular Diagnostics Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−11.3K sh	$4.11	−$46.4K	206,060
2026-03-26	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−28.3K sh	—	—	84,905
2025-10-31	IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+50K sh	—	—	201,231
2025-10-31	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsD Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	+50K sh	—	—	50,000
2025-10-31	IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+50K sh	—	—	201,231
2025-10-31	IMDXInsight Molecular Diagnostics Inc.F Tax Payment	Chief Financial Officer	FTax Payment	−12.2K sh	$6.01	−$73.2K	189,056
2025-10-31	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−50K sh	—	—	50,000
2025-09-28	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+235K sh	—	—	235,000
2025-03-26	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+113K sh	—	—	113,207
2025-02-07	IMDXInsight Molecular Diagnostics Inc.P Purchase	Chief Financial Officer	PPurchase	+97.6K sh	$2.05	+$200K	151,231
2024-12-05	IMDXInsight Molecular Diagnostics Inc.P Purchase	Chief Financial Officer	PPurchase	+20K sh	$2.29	+$45.8K	53,670
2024-10-11	IMDXInsight Molecular Diagnostics Inc. · Options to Purchase Common StockA Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2024-10-11	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2024-10-02	IMDXInsight Molecular Diagnostics Inc.P Purchase	Chief Financial Officer	PPurchase	+33.7K sh	$2.97	+$100K	33,670
2024-06-20	IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award	Chief Financial Officer	AAward	+200K sh	—	—	200,000
2024-06-20	IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+100K sh	—	—	300,000

Recent filings

Accepted (ET)
Mar 304
James Andrea S.0001493152-26-013574
SEC(opens sec.gov)
Nov 134/A
James Andrea S.0001493152-25-022358
SEC(opens sec.gov)
Nov 44
James Andrea S.0001493152-25-020719
SEC(opens sec.gov)
Sep 304
James Andrea S.0001493152-25-016349
SEC(opens sec.gov)
Mar 284
James Andrea S.0001641172-25-001181
SEC(opens sec.gov)
Feb 114
James Andrea S.0001493152-25-005978
SEC(opens sec.gov)
Dec 94
James Andrea S.0001493152-24-049195
SEC(opens sec.gov)
Oct 154
James Andrea S.0001493152-24-041131
SEC(opens sec.gov)
Oct 44
James Andrea S.0001493152-24-039603
SEC(opens sec.gov)
Jun 244
James Andrea S.0001493152-24-024981
SEC(opens sec.gov)

Companies

Insight Molecular Diagnostics Inc.Chief Financial OfficerIMDX

Address

C/O INSIGHT MOLECULAR DIAGNOSTICS INC. 2 INTERNATIONAL PLAZA, SUITE 510

NASHVILLE, TN, 37217